In our previous study, we found that ROS levels were significantly increased in ovarian cancer cells compared with normal cells, which regulated hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF) expression, and induced angiogenesis and tumor growth [5]. Here, HIF1A is linked to neoplasm.